Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Lake

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001
Lack of ignorance to tumor antigens: evaluation using nominal antigen transfection and T-cell receptor transgenic lymphocytes in Lyons-Parish analysis--implications for tumor toleranceB W Robinson, B M Scott, R A Lake, et al.
Cell Proliferation|December 2, 2008
Spontaneously immortalized mouse mesothelial cells display characteristics of malignant transformationA L Sherwood, S E Mutsaers, V K Peeva, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2000
Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunityA L Marzo, B F Kinnear, R A Lake, et al.
Scientific Reports|November 26, 2016
A Subset of Malignant Mesothelioma Tumors Retain Osteogenic PotentialS M Lansley, B Pedersen, C Robinson, et al.
British Journal of Cancer|December 10, 2015
Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancerM J McCoy, C Hemmings, T J Miller, et al.
Lupus|February 1, 1993
Expression and relationships of seven public idiotypes of DNA-binding autoantibodies on monoclonal antibodies and serum immunoglobulinsN A Staines, C T Ravirajan, A Morgan, et al.
Cancer Gene Therapy|June 1, 2000
Replication-restricted vaccinia as a cytokine gene therapy vector in cancer: persistent transgene expression despite antibody generationS Mukherjee, T Haenel, R Himbeck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 20, 2015
A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesotheliomaA K Nowak, A M Cook, A M McDonnell, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001
Lack of ignorance to tumor antigens: evaluation using nominal antigen transfection and T-cell receptor transgenic lymphocytes in Lyons-Parish analysis--implications for tumor toleranceB W Robinson, B M Scott, R A Lake, et al.
Cell Proliferation|December 2, 2008
Spontaneously immortalized mouse mesothelial cells display characteristics of malignant transformationA L Sherwood, S E Mutsaers, V K Peeva, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2000
Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunityA L Marzo, B F Kinnear, R A Lake, et al.
Scientific Reports|November 26, 2016
A Subset of Malignant Mesothelioma Tumors Retain Osteogenic PotentialS M Lansley, B Pedersen, C Robinson, et al.
British Journal of Cancer|December 10, 2015
Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancerM J McCoy, C Hemmings, T J Miller, et al.
Lupus|February 1, 1993
Expression and relationships of seven public idiotypes of DNA-binding autoantibodies on monoclonal antibodies and serum immunoglobulinsN A Staines, C T Ravirajan, A Morgan, et al.
Cancer Gene Therapy|June 1, 2000
Replication-restricted vaccinia as a cytokine gene therapy vector in cancer: persistent transgene expression despite antibody generationS Mukherjee, T Haenel, R Himbeck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 20, 2015
A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesotheliomaA K Nowak, A M Cook, A M McDonnell, et al.
Pageof 5